Back to Journals » Lung Cancer: Targets and Therapy » Volume 15

Commentary

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?

       
Total article views   HTML views PDF downloads Totals
2,783 Dovepress* 2,277+ 43 2,320
PubMed Central* 506 113 619
Totals 2,783 156 2,939
*Since 12 April 2024

View citations on PubMed and Google Scholar